Ukubuyekezwa kweMammoSite Breast Radiation Therapy

I-bramytherapy yebele yamaMamSSite wuhlobo lokuphulukiswa kwe-radiation lesifuba esheshayo. Ngezinye izikhathi kuthiwa yi-balloon catheter imisebe, i-MammoSite isebenzisa umdlavuza webele ngaphakathi kwesifuba sakho ezinsukwini ezingu-5-nemiphumela emibi kakhulu kune-course standard yezinyanga eziyisithupha noma eziyisikhombisa zemisebe yangaphandle .

I-Breast Radiation Ngemuva kweLumpectomy

I-radiation ingasetshenziselwa ukwelapha umdlavuza webele ngemva kokuba isisu sakho sisusiwe nge- lumpectomy .

Imithi yokwelashwa isenziwa ukuze kuvinjelwe ukuphindaphindiwe ngokuqinisekisa ukuthi noma yimaphi amangqamuzana omdlavuza angase ahlale endaweni yesisu abhujiswa.

Ukwelashwa kwemisebe yamaMamSSite, uhlobo lwe- brachytherapy engathandwayo , luhlukile kunezimoto zangaphandle ze-beam-linikeza imisebe esuka ngaphakathi kwebele lakho futhi lithinta ingxenye encane kakhulu yezicubu ezinempilo.

I-MammoSite Breastytherapy

I-MammoSite yayingu-FDA evunyelwe ngo-2002 ukuze kutholakale ukwelashwa komdlavuza we-post-lumpectomy. I-balloon ene-multi-lumen yavunywa ngo-2009. I-MammoSite Radiation Therapy System isebenzisa i-balathon ekhethekile ye-balathon, efakwe ku-lumpectomy yakho cavity futhi igcwele isisombululo saline. Udokotela wakho ohlinzayo angabeka i-balmoon catheter ye-MammoSite ngesikhathi se-lumpectomy yakho, noma ingabe ifakwe esikhathini esizayo.

Izinzuzo ezingenzeka

Ukungalungi

Yini Ongayilindela Phakathi Nokwelapha

Ukwelashwa kweMammoSite kwenziwa kabili ngosuku ngezinsuku eziyisihlanu ezilandelanayo. Ukuqokwa kwakho kokwelapha kuzothatha cishe imizuzu engama-30.

Ngesikhathi ukwelashwa kwama-radiation, i-oncologist yakho ye-radiation izoxhuma umzila wakho we-MammoSite ngomshini wokushisa imishanguzo, futhi ufake imbewu encane ye-radioactive emgqonyeni, lapho ikhipha umthamo wakho we-radiation. Ngeke uzizwe ukushisa noma ukudlidliza ngesikhathi sokwelashwa. Ekupheleni kweseshini yokwelapha ngayinye, imbewu isusiwe futhi ngeke ukwazi ukuthwala imisebe ehambisana nawe phakathi kwezokwelapha. Uma noma yimaphi amangqamuzana omdlavuza ahlala emathisheni azungeze umkhawulo wakho wokugqoka, ama-radiation kufanele awabulale.

Ngemuva kwezinsuku ezingu-5, i-catheter ibhaluni idonswa ngosawoti bese isuswa ngesikhumba esincane esivaliwe ngokugqoka.

Ukubuyisela

Ungase ube nemiphumela emibi ngesikhathi noma ngemuva kokwelashwa kwama-MammoSite brachytherapy. Lezi zizocaca ngokunakekelwa okufanele, kodwa qiniseka ukuthi uya kuma-aphoyintimenti wakho wokulandelela, futhi uvumele udokotela wakho wazi uma unenkinga ngokuthola.

Ungalindela ukubomvu noma ukulimaza eduze kwesayithi lokufaka indawo ye-catheter. Kungase kube khona ubuhlungu noma umcibisholo kusuka ebomvu ngaphambi kokuba uphulukise. Qaphela ukugcina le ndawo ihlanzekile futhi yomile. Abanye besifazane bangase bahlakulele ukusabela isikhumba noma ukuqhuma.

Uma ukubomvu kwesikhumba kuqhubeka, noma indawo iyazikhukhumeza noma ibukeka igubha, bheka udokotela wakho ngokushesha ukuze unqume ukuthi ngabe unesifo.

I-MammoSite Inomlando Wokulandelela I-Track

Ngokwesifundo se-2014 ku- International Journal of Radiation Oncology, esihlolisisa abesifazane abangaphezu kuka-100 ababesebenza nge-balmoon brachytherapy, imiphumela yabonisa ukuthi i-tumor isilawuli esihle kakhulu ekulandeleni iminyaka engama-5.5.

Olunye u-2011 olwenziwe ku- Annals of Oncology Surgical landela abesifazane abangaba ngu-200 abasebenzisa i-MammoSite ngesivinini se-breast-radiation (APBI) esiphuthumayo (APBI) ekwelapheni i-ductal carcinoma in situ (i-DCIS) ngemuva kwe-lumpectomy. Kwakunakekelwa kahle futhi izinga lokuphindaphinda kwendawo ngemuva kweminyaka emihlanu laliyi-3.39%.

Izidingo

I-MammoSite ivame ukwelashwa kwe-ductal carcinoma in situ (i-DCIS), i-ductal carcinoma (i-IDC) engavamile, nesisu esiyinhloko esingama-3 cm noma esincane ngobukhulu.

Udokotela wakho ohlinzayo kufanele akwazi ukushiya okungenani amamitha ayizi-7 ezicubu phakathi kwesikhumba sakho ne-balloon egcwele ngokugcwele. Futhi, i-lumpectomy yakho cavity idinga ukufana ne-globular ngangokunokwenzeka ukuze ubeke ibhaluni; uma kungenjalo imithi ngeke isebenze kahle.

Kwezinye izimo, idivayisi yeMammoSite kumele ihlelwe kabusha imiphumela emihle. Khetha udokotela ohlinzayo owazi kahle kakhulu ukubeka idivayisi yeMammoSite, futhi abuze ukuthi ngabe isibhedlela sinemishini edingekayo yini yokufaka nokubeka isikhala.

Imithombo:

Bensaleh S, Bezak E, & Borg M. Ukubuyekezwa kwe-MammoSite bracytherapy: Izinzuzo, ukungalungi nemiphumela yomtholampilo. I-Acta Oncol. 2009; 48 (4): 487-94.

Jeruss JS et al. Imiphumela yokuqala yeziguli eziphathwe ku-American Society ye-Breast Surgeons MammSite trial trial for ductal carcinoma-in-situ yebele. U-Ann Surg Oncol, 2006. 13 (7): iphe. 967-76.

Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, & Keisch M. Ukubuyekezwa kwemiphumela ye-DCIS evela ku-American Society of Breast Surgeons Isheshayo se-Bretial Irradiation Registry Trial. I-Ann Surg Oncol. 2011 Jan; 18 (1): 65-71.

Vargo Ja et al. Imiphumela enwetshiwe (eminyaka emihlanu) yokwehliswa kwebele okuphuthumayo okuphuthumayo usebenzisa i-MammoSite balloon bracytherapy: amaphethini okuhluleka, ukhetho lwesiguli, kanye ne-dosimetric correlates ye-poisonous late. I-Int J Radiat Oncol Biol Phys. 2014 Feb 1; 88 (2): 285-91.